Acorah Software Products - Accounts Production 19.2.350 false true true 31 August 2024 1 September 2023 false 1 September 2024 31 August 2025 31 August 2025 15067277 H De Salgado Salgado iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15067277 2024-08-31 15067277 2025-08-31 15067277 2024-09-01 2025-08-31 15067277 frs-core:CurrentFinancialInstruments 2025-08-31 15067277 frs-core:ComputerEquipment 2025-08-31 15067277 frs-core:ComputerEquipment 2024-09-01 2025-08-31 15067277 frs-core:ComputerEquipment 2024-08-31 15067277 frs-core:PlantMachinery 2025-08-31 15067277 frs-core:PlantMachinery 2024-09-01 2025-08-31 15067277 frs-core:PlantMachinery 2024-08-31 15067277 frs-core:SharePremium 2025-08-31 15067277 frs-core:ShareCapital 2025-08-31 15067277 frs-core:RetainedEarningsAccumulatedLosses 2025-08-31 15067277 frs-bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 15067277 frs-bus:FilletedAccounts 2024-09-01 2025-08-31 15067277 frs-bus:SmallEntities 2024-09-01 2025-08-31 15067277 frs-bus:AuditExempt-NoAccountantsReport 2024-09-01 2025-08-31 15067277 frs-bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 15067277 frs-bus:Director1 2024-09-01 2025-08-31 15067277 frs-countries:EnglandWales 2024-09-01 2025-08-31 15067277 2023-08-31 15067277 2024-08-31 15067277 2023-09-01 2024-08-31 15067277 frs-core:CurrentFinancialInstruments 2024-08-31 15067277 frs-core:SharePremium 2024-08-31 15067277 frs-core:ShareCapital 2024-08-31 15067277 frs-core:RetainedEarningsAccumulatedLosses 2024-08-31
Registered number: 15067277
Owlistic Therapies Limited
Unaudited Financial Statements
For The Year Ended 31 August 2025
M A Accountancy Group
Wolfe Mead
Farnham Road
Bordon
Hampshire
GU35 0NH
Owlistic Therapies Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—5

Page 1
Owlistic Therapies Limited
Balance Sheet
As At 31 August 2025
Balance Sheet
Registered number: 15067277

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 1,615 |  | 1,881
|  |  | 1,615 |  | 1,881
CURRENT ASSETS
Stocks | 5 | 4,042 |  | 3,000 |
Debtors | 6 | - |  | 277 |
Cash at bank and in hand |  | 188 |  | 158 |
|  | 4,230 |  | 3,435 |
Creditors: Amounts Falling Due Within One Year | 7 | (7,109 ) |  | (6,627 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | (2,879 ) |  | (3,192 )
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | (1,264 ) |  | (1,311 )
NET LIABILITIES |  |  | (1,264 ) |  | (1,311 )
CAPITAL AND RESERVES
Called up share capital | 8 |  | 4 |  | 4
Share premium account |  |  | 24 |  | 24
Profit and Loss Account |  |  | (1,292 ) |  | (1,339 )
SHAREHOLDERS' FUNDS |  |  | (1,264) |  | (1,311)

Page 1
Page 2
Owlistic Therapies Limited
Balance Sheet (continued)
As At 31 August 2025
For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

H De Salgado Salgado Director
15th May 2026

The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Owlistic Therapies Limited
Notes to the Financial Statements
For The Year Ended 31 August 2025
Notes to the Financial Statements
1. General Information
Owlistic Therapies Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15067277 . The registered office is Martinique House, Hampshire Road, Bordon, GU35 0HJ .
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Going Concern Disclosure
The financial statements have been prepared on a going concern basis. The Company has incurred losses and, at the balance sheet date, its liabilities exceeded its assets. The Company is dependent on ongoing financial support from its director to meet its liabilities as they fall due.
The director has confirmed that they will continue to provide financial support to the Company for a period of at least twelve months from the date of approval of these financial statements. On this basis, the directors consider it appropriate to prepare the financial statements on a going concern basis.
2.3. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.4. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Plant & Machinery | 25% reducing balance
Computer Equipment | Over 5 years

Page 3
Page 4
Owlistic Therapies Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 August 2025
2.5. Stocks and Work in Progress
Stocks and work in progress are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads. Work-in-progress is reflected in the accounts on a contract by contract basis by recording turnover and related costs as contract activity progresses.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Tangible Assets

| Plant & Machinery | Computer Equipment | Total
--- | --- | --- | ---
| £ | £ | £
Cost
As at 1 September 2024 | 1,249 | 953 | 2,202
As at 31 August 2025 | 1,249 | 953 | 2,202
Depreciation
As at 1 September 2024 | 130 | 191 | 321
Provided during the period | 114 | 152 | 266
As at 31 August 2025 | 244 | 343 | 587
Net Book Value
As at 31 August 2025 | 1,005 | 610 | 1,615
As at 1 September 2024 | 1,119 | 762 | 1,881

5. Stocks

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Stock | 4,042 |  | 3,000

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | - |  | 277

Page 4
Page 5
Owlistic Therapies Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 August 2025
7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other loans | 5,721 |  | 5,276
Other creditors | 1,388 |  | 1,351
| 7,109 |  | 6,627

8. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 4 |  | 4

9. Related Party Transactions
At the balance sheet date there was a loan outstanding from the director of £1,034 (2024 - £391), which has been included in other creditors. The loan is interest free, unsecured and repayable on demand
At the Balance sheet date Gareth Turner a director from the Shareholding company has provided a loan to the business of £5,721 (2024 - £5,276), which has been included in other creditors. This loan is interest free, unsecured and repayable on demand.
Page 5